Elanco Animal Health (ELAN) Misses Q4 EPS by 2c ; Offers Guidance

Elanco Animal Health (NYSE: ELAN) reported Q4 EPS of $0.08, $0.02 worse than the analyst estimate of $0.10. Revenue for the quarter came in at $1.04 billion versus the consensus estimate of $1 billion.

GUIDANCE:

Elanco Animal Health sees FY2024 EPS of $0.87-$0.95, versus the consensus of $0.89. Elanco Animal Health sees FY2024 revenue of $4.45-4.54 billion, versus the consensus of $4.51 billion.

For earnings history and earnings-related data on Elanco Animal Health (ELAN) click here.

You May Also Be Interested In

• United Natural Foods (UNFI) Tops Q4 EPS by 8c ; Offers Guidance
• ASP Isotopes holds first capital markets day, targets $300M EBITDA by 2031
• UBS upgrades Lockheed Martin to Buy, sees 26% upside on missile growth